Geneva, Sept. 23 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2071250068) titled 'A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers' on Sept. 10.
Study Type: Interventional
Study Design:
randomized controlled trial, single blind, placebo control, parallel assignment, other
Primary Sponsor: Myoishi Masafumi
Condition:
Sepsis associated disseminated intravascularcoagulation
Intervention:
Dose Step 1 BAY 3389934
15 mg/h/ intravenous Single Dose for 4 hfasting
Dose Step 2 BAY 3389934
Max. dose 35 mg / h / intravenous - actual dose will be determined after Dose Step 1Single Dose for 4 h fasting
Dose Step 1 ...